Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions

Pathogens

Volumn 3, Issue 2, 2014, Pages 377-389

  Inuzuka, Tadashi ^a   Takahashi, Ken ^a   Chiba, Tsutomu ^a   Marusawa, Hiroyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Animal model; Humanized mouse; Immune response; Transgenic mouse

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 8; CIRCULAR DNA; FK 506 BINDING PROTEIN; GAMMA INTERFERON; SMALL INTERFERING RNA; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; DISEASE MODEL; GENE EXPRESSION; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMANIZED MOUSE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 84936776606     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens3020377     Document Type: Review

References (69)

1. Lee, W. M. Hepatitis B virus infection. N. Engl. J. Med. 1997, 337, 1733-1745.
2. Lai, C. L.; Ratziu, V.; Yuen, M. F.; Poynard, T. Viral hepatitis B. Lancet 2003, 362, 2089-2094.
3. Ganem, D.; Prince, A. M. Hepatitis B virus infection--natural history and clinical consequences. N. Engl. J. Med. 2004, 350, 1118-1129.
4. Dandri, M.; Volz, T. K.; Lutgehetmann, M.; Petersen, J. Animal models for the study of HBV replication and its variants. J. Clin. Virol. 2005, 34(Suppl. S1), S54-S62.
5. Walter, E.; Keist, R.; Niederost, B.; Pult, I.; Blum, H. E. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996, 24, 1-5.
6. Barker, L. F.; Chisari, F. V.; McGrath, P. P.; Dalgard, D. W.; Kirschstein, R. L.; Almeida, J. D.; Edington, T. S.; Sharp, D. G.; Peterson, M. R. Transmission of type B viral hepatitis to chimpanzees. J. Infect. Dis. 1973, 127, 648-662.
7. Chisari, F. V.; Pinkert, C. A.; Milich, D. R.; Filippi, P.; McLachlan, A.; Palmiter, R. D.; Brinster, R. L. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985, 230, 1157-1160.
8. Chisari, F. V.; Filippi, P.; McLachlan, A.; Milich, D. R.; Riggs, M.; Lee, S.; Palmiter, R. D.; Pinkert, C. A.; Brinster, R. L. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J. Virol. 1986, 60, 880-887.
9. Gilles, P. N.; Fey, G.; Chisari, F. V. Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 1992, 66, 3955-3960.
10. Guidotti, L. G.; Martinez, V.; Loh, Y. T.; Rogler, C. E.; Chisari, F. V. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J. Virol. 1994, 68, 5469-5475.
11. Milich, D. R.; Jones, J. E.; Hughes, J. L.; Maruyama, T.; Price, J.; Melhado, I.; Jirik, F. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice. J. Immunol. 1994, 152, 455-466.
12. Milich, D. R.; Jones, J. E.; Hughes, J. L.; Price, J.; Raney, A. K.; McLachlan, A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA 1990, 87, 6599-6603.
13. Kim, C. M.; Koike, K.; Saito, I.; Miyamura, T.; Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991, 351, 317-320.
14. Koike, K.; Moriya, K.; Iino, S.; Yotsuyanagi, H.; Endo, Y.; Miyamura, T.; Kurokawa, K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994, 19, 810-819.
15. Araki, K.; Miyazaki, J.; Hino, O.; Tomita, N.; Chisaka, O.; Matsubara, K.; Yamamura, K. Expression and replication of hepatitis B virus genome in transgenic mice. Proc. Natl. Acad. Sci. USA 1989, 86, 207-211.
16. Guidotti, L. G.; Matzke, B.; Schaller, H.; Chisari, F. V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 1995, 69, 6158-6169.
17. Guidotti, L. G.; Rochford, R.; Chung, J.; Shapiro, M.; Purcell, R.; Chisari, F. V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284, 825-829.
18. Guidotti, L. G.; Ishikawa, T.; Hobbs, M. V.; Matzke, B.; Schreiber, R.; Chisari, F. V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4, 25-36.
19. Thimme, R.; Wieland, S.; Steiger, C.; Ghrayeb, J.; Reimann, K. A.; Purcell, R. H.; Chisari, F. V. Cd8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 2003, 77, 68-76.
20. Sitia, G.; Isogawa, M.; Kakimi, K.; Wieland, S. F.; Chisari, F. V.; Guidotti, L. G. Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 2002, 99, 13717-13722.
21. Sitia, G.; Isogawa, M.; Iannacone, M.; Campbell, I. L.; Chisari, F. V.; Guidotti, L. G. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J. Clin. Invest. 2004, 113, 1158-1167.
22. Sitia, G.; Iannacone, M.; Aiolfi, R.; Isogawa, M.; van Rooijen, N.; Scozzesi, C.; Bianchi, M. E.; von Andrian, U. H.; Chisari, F. V.; Guidotti, L. G. Kupffer cells hasten resolution of liver immunopathology in mouse models of viral hepatitis. PLoS Pathog. 2011, 7, e1002061.
23. Kakimi, K.; Lane, T. E.; Wieland, S.; Asensio, V. C.; Campbell, I. L.; Chisari, F. V.; Guidotti, L. G. Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 2001, 194, 1755-1766.
24. Iannacone, M.; Sitia, G.; Isogawa, M.; Marchese, P.; Castro, M. G.; Lowenstein, P. R.; Chisari, F. V.; Ruggeri, Z. M.; Guidotti, L. G. Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat. Med. 2005, 11, 1167-1169.
25. Iannacone, M.; Sitia, G.; Ruggeri, Z. M.; Guidotti, L. G. HBV pathogenesis in animal models: Recent advances on the role of platelets. J. Hepatol. 2007, 46, 719-726.
26. McClary, H.; Koch, R.; Chisari, F. V.; Guidotti, L. G. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 2000, 74, 2255-2264.
27. Kakimi, K.; Guidotti, L. G.; Koezuka, Y.; Chisari, F. V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 2000, 192, 921-930.
28. Weber, O.; Schlemmer, K. H.; Hartmann, E.; Hagelschuer, I.; Paessens, A.; Graef, E.; Deres, K.; Goldmann, S.; Niewoehner, U.; Stoltefuss, J.; et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res. 2002, 54, 69-78.
29. Julander, J. G.; Sidwell, R. W.; Morrey, J. D. Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Res. 2002, 55, 27-40.
30. Julander, J. G.; Colonno, R. J.; Sidwell, R. W.; Morrey, J. D. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. Antiviral Res. 2003, 59, 155-161.
31. McCaffrey, A. P.; Nakai, H.; Pandey, K.; Huang, Z.; Salazar, F. H.; Xu, H.; Wieland, S. F.; Marion, P. L.; Kay, M. A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 2003, 21, 639-644.
32. Klein, C.; Bock, C. T.; Wedemeyer, H.; Wustefeld, T.; Locarnini, S.; Dienes, H. P.; Kubicka, S.; Manns, M. P.; Trautwein, C. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology 2003, 125, 9-18.
33. Ebert, G.; Poeck, H.; Lucifora, J.; Baschuk, N.; Esser, K.; Esposito, I.; Hartmann, G.; Protzer, U. 5' triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice. Gastroenterology 2011, 141, 696-706.
34. Yan, H.; Zhong, G.; Xu, G.; He, W.; Jing, Z.; Gao, Z.; Huang, Y.; Qi, Y.; Peng, B.; Wang, H.; et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012, 1, e00049.
35. Levrero, M.; Pollicino, T.; Petersen, J.; Belloni, L.; Raimondo, G.; Dandri, M. Control of cccDNA function in hepatitis B virus infection. J. Hepatol. 2009, 51, 581-592.
36. Lucifora, J.; Xia, Y.; Reisinger, F.; Zhang, K.; Stadler, D.; Cheng, X.; Sprinzl, M. F.; Koppensteiner, H.; Makowska, Z.; Volz, T.; et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 2014, 343, 1221-1228.
37. Publicover, J.; Goodsell, A.; Nishimura, S.; Vilarinho, S.; Wang, Z. E.; Avanesyan, L.; Spolski, R.; Leonard, W. J.; Cooper, S.; Baron, J. L. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J. Clin. Invest. 2011, 121, 1154-1162.
38. Publicover, J.; Gaggar, A.; Nishimura, S.; Van Horn, C. M.; Goodsell, A.; Muench, M. O.; Reinhardt, R. L.; van Rooijen, N.; Wakil, A. E.; Peters, M.; et al. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J. Clin. Invest. 2013, 123, 3728-3739.
39. Yang, P. L.; Althage, A.; Chung, J.; Chisari, F. V. Hydrodynamic injection of viral DNA: A mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 2002, 99, 13825-13830.
40. Huang, L. R.; Wu, H. L.; Chen, P. J.; Chen, D. S. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 2006, 103, 17862-17867.
41. Yang, P. L.; Althage, A.; Chung, J.; Maier, H.; Wieland, S.; Isogawa, M.; Chisari, F. V. Immune effectors required for hepatitis B virus clearance. Proc. Natl. Acad. Sci. USA 2010, 107, 798-802.
42. Rehermann, B. Pathogenesis of chronic viral hepatitis: Differential roles of T cells and NK cells. Nat. Med. 2013, 19, 859-868.
43. Dion, S.; Bourgine, M.; Godon, O.; Levillayer, F.; Michel, M. L. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J. Virol. 2013, 87, 5554-5563.
44. Yang, D.; Liu, L.; Zhu, D.; Peng, H.; Su, L.; Fu, Y. X.; Zhang, L. A mouse model for HBV immunotolerance and immunotherapy. Cell. Mol. Immunol. 2014, 11, 71-78.
45. Ilan, E.; Burakova, T.; Dagan, S.; Nussbaum, O.; Lubin, I.; Eren, R.; Ben-Moshe, O.; Arazi, J.; Berr, S.; Neville, L.; et al. The hepatitis B virus-trimera mouse: A model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology 1999, 29, 553-562.
46. Heckel, J. L.; Sandgren, E. P.; Degen, J. L.; Palmiter, R. D.; Brinster, R. L. Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 1990, 62, 447-456.
47. Rhim, J. A.; Sandgren, E. P.; Palmiter, R. D.; Brinster, R. L. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc. Natl. Acad. Sci. USA 1995, 92, 4942-4946.
48. Dandri, M.; Burda, M. R.; Torok, E.; Pollok, J. M.; Iwanska, A.; Sommer, G.; Rogiers, X.; Rogler, C. E.; Gupta, S.; Will, H.; et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001, 33, 981-988.
49. Mercer, D. F.; Schiller, D. E.; Elliott, J. F.; Douglas, D. N.; Hao, C.; Rinfret, A.; Addison, W. R.; Fischer, K. P.; Churchill, T. A.; Lakey, J. R.; et al. Hepatitis C virus replication in mice with chimeric human livers. Nat. Med. 2001, 7, 927-933.
50. Tateno, C.; Yoshizane, Y.; Saito, N.; Kataoka, M.; Utoh, R.; Yamasaki, C.; Tachibana, A.; Soeno, Y.; Asahina, K.; Hino, H.; et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol. 2004, 165, 901-912.
51. Brezillon, N. M.; DaSilva, L.; L'Hote, D.; Bernex, F.; Piquet, J.; Binart, N.; Morosan, S.; Kremsdorf, D. Rescue of fertility in homozygous mice for the urokinase plasminogen activator transgene by the transplantation of mouse hepatocytes. Cell Transplant. 2008, 17, 803-812.
52. Azuma, H.; Paulk, N.; Ranade, A.; Dorrell, C.; Al-Dhalimy, M.; Ellis, E.; Strom, S.; Kay, M. A.; Finegold, M.; Grompe, M. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/-mice. Nat. Biotechnol. 2007, 25, 903-910.
53. Bissig, K. D.; Wieland, S. F.; Tran, P.; Isogawa, M.; Le, T. T.; Chisari, F. V.; Verma, I. M. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J. Clin. Invest. 2010, 120, 924-930.
54. Tsuge, M.; Hiraga, N.; Takaishi, H.; Noguchi, C.; Oga, H.; Imamura, M.; Takahashi, S.; Iwao, E.; Fujimoto, Y.; Ochi, H.; et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology 2005, 42, 1046-1054.
55. Meuleman, P.; Libbrecht, L.; De Vos, R.; de Hemptinne, B.; Gevaert, K.; Vandekerckhove, J.; Roskams, T.; Leroux-Roels, G. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 2005, 41, 847-856.
56. Sugiyama, M.; Tanaka, Y.; Kato, T.; Orito, E.; Ito, K.; Acharya, S. K.; Gish, R. G.; Kramvis, A.; Shimada, T.; Izumi, N.; et al. Influence of hepatitis B virus genotypes on the intra-and extracellular expression of viral DNA and antigens. Hepatology 2006, 44, 915-924.
57. Dandri, M.; Burda, M. R.; Zuckerman, D. M.; Wursthorn, K.; Matschl, U.; Pollok, J. M.; Rogiers, X.; Gocht, A.; Kock, J.; Blum, H. E.; et al. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J. Hepatol. 2005, 42, 54-60.
58. Petersen, J.; Dandri, M.; Mier, W.; Lutgehetmann, M.; Volz, T.; von Weizsacker, F.; Haberkorn, U.; Fischer, L.; Pollok, J. M.; Erbes, B.; et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat. Biotechnol. 2008, 26, 335-341.
59. Yatsuji, H.; Noguchi, C.; Hiraga, N.; Mori, N.; Tsuge, M.; Imamura, M.; Takahashi, S.; Iwao, E.; Fujimoto, Y.; Ochi, H.; et al. Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif. Antimicrob. Agents Chemother. 2006, 50, 3867-3874.
60. Belloni, L.; Allweiss, L.; Guerrieri, F.; Pediconi, N.; Volz, T.; Pollicino, T.; Petersen, J.; Raimondo, G.; Dandri, M.; Levrero, M. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J. Clin. Invest. 2012, 122, 529-537.
61. Ploss, A.; Evans, M. J.; Gaysinskaya, V. A.; Panis, M.; You, H.; de Jong, Y. P.; Rice, C. M. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009, 457, 882-886.
62. Dorner, M.; Horwitz, J. A.; Robbins, J. B.; Barry, W. T.; Feng, Q.; Mu, K.; Jones, C. T.; Schoggins, J. W.; Catanese, M. T.; Burton, D. R.; et al. A genetically humanized mouse model for hepatitis C virus infection. Nature 2011, 474, 208-211.
63. Dorner, M.; Horwitz, J. A.; Donovan, B. M.; Labitt, R. N.; Budell, W. C.; Friling, T.; Vogt, A.; Catanese, M. T.; Satoh, T.; Kawai, T.; et al. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 2013, 501, 237-241.
64. Nkongolo, S.; Ni, Y.; Lempp, F. A.; Kaufman, C.; Lindner, T.; Esser-Nobis, K.; Lohmann, V.; Mier, W.; Mehrle, S.; Urban, S. Cyclosporin a inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. J. Hepatol. 2014, 60, 723-731.
65. Iwamoto, M.; Watashi, K.; Tsukuda, S.; Aly, H. H.; Fukasawa, M.; Fujimoto, A.; Suzuki, R.; Aizaki, H.; Ito, T.; Koiwai, O.; et al. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochem. Biophys. Res. Commun. 2014, 443, 808-813.
66. Watashi, K.; Urban, S.; Li, W.; Wakita, T. NTCP and beyond: Opening the door to unveil hepatitis B virus entry. Int. J. Mol. Sci. 2014, 15, 2892-2905.
67. Li, H.; Zhuang, Q.; Wang, Y.; Zhang, T.; Zhao, J.; Zhang, Y.; Zhang, J.; Lin, Y.; Yuan, Q.; Xia, N.; et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell. Mol. Immunol. 2014, 11, 175-183.
68. Washburn, M. L.; Bility, M. T.; Zhang, L.; Kovalev, G. I.; Buntzman, A.; Frelinger, J. A.; Barry, W.; Ploss, A.; Rice, C. M.; Su, L. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011, 140, 1334-1344.
69. Blumberg, B. S.; Alter, H. J.; Visnich, S. A "new" antigen in leukemia sera. J. Am. Med. Assoc. 1965, 191, 541-546.